News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Pontifax Management 4 G.P. (2015) Ltd.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/30/2022 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,539 options to buy
@ $0.0001, valued at
$0.4
Exercised (in-or-at-the-money) 1,723 options to buy
@ $0.0001, valued at
$0.2
Exercised (in-or-at-the-money) 1,914 options to buy
@ $0.0001, valued at
$0.2 |
|
| 11/30/2022 |
3/A
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 3/A on Keros Therapeutics, Inc. |
| 05/17/2021 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 1,280,624 shares
@ $1.35, valued at
$1.7M
Bought 2,630,487 shares
@ $1.35, valued at
$3.6M
Bought 1,422,222 shares
@ $1.35, valued at
$1.9M
Bought 592,592 shares
@ $1.35, valued at
$800k
|
|
| 11/19/2020 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Bought 26,634 shares
@ $50, valued at
$1.3M
Bought 12,966 shares
@ $50, valued at
$648.3k
Bought 14,400 shares
@ $50, valued at
$720k
Bought 6,000 shares
@ $50, valued at
$300k
|
|
| 05/22/2020 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.39, valued at
$67.8k
Granted 20,000 options to buy
@ $3.39, valued at
$67.8k
|
|
| 04/23/2020 |
SC 13D
| Pontifax Management 4 G.P. Ltd. reports a 23.6% stake in Keros Therapeutics, Inc. |
| 04/13/2020 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Converted 1,363,542 shares
@ $0
Converted 663,825 shares
@ $0
Converted 737,226 shares
@ $0
Converted 169,307 shares
@ $0
Converted 82,425 shares
@ $0
Converted 91,538 shares
@ $0
Converted 68,654 shares
@ $0
Converted 163,612 shares
@ $0
Converted 88,460 shares
@ $0
Converted 79,653 shares
@ $0
Converted 36,858 shares
@ $0 |
|
| 04/07/2020 |
3
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 3 on Keros Therapeutics, Inc. |
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2019 |
3
| Kariv Tomer (10% Owner) has filed a Form 3 on 89bio, Inc. |
| 09/19/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2019 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.02, valued at
$180.4k
Granted 20,000 options to buy
@ $9.02, valued at
$180.4k
|
|
| 06/19/2018 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $23.27, valued at
$930.8k
Granted 40,000 options to buy
@ $23.27, valued at
$930.8k
|
|
| 05/01/2018 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 84,041 shares
@ $9.75, valued at
$819.4k
Bought 172,626 shares
@ $9.75, valued at
$1.7M
Bought 93,333 shares
@ $9.75, valued at
$910k
|
|
| 03/23/2018 |
4
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 1,585 shares
@ $7.55, valued at
$12k
Bought 3,255 shares
@ $7.55, valued at
$24.6k
Bought 1,760 shares
@ $7.55, valued at
$13.3k
Bought 1,441 shares
@ $8, valued at
$11.5k
Bought 2,959 shares
@ $8, valued at
$23.7k
Bought 1,600 shares
@ $8, valued at
$12.8k
|
|
| 12/29/2017 |
3
| Pontifax Management 4 G.P. (2015) Ltd. (10% Owner) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 12/29/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|